WAVEMAN · COMPANY

SNES · Senestech, Inc.

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

SNES

Name: SenesTech, Inc. (SNES) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

SenesTech, Inc.

PHARMA & BIOTECH · AGRICULTURAL CHEMICALS · CIK 0001680378

ACTIVIST 13DC-SUITE BUYING · 1☆ WATCH

INSIDER NET · 180D

$627.3K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+19.6%

XBRL, annual

NET MARGIN

-287.4%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$627.3K over 180 days

+$200.3K over 90 days · +$618.1K of it by a 10%+ holder

more than 86% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

5 funds added or opened last quarter

below 96% of Pharma & Biotech

REVENUE

+19.6% year over year

more than 68% of Pharma & Biotech

MARGIN

-287.4% net margin

below 76% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

GLENBROOK CAPITAL MANAGEMENT disclosed a 5%+ stake (19.95%) in the last six months.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -78.8%

-78.8%12M

INSIDER BUYINSIDER SELL13D/G STAKE

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

An activist crossed the 5% line with declared intent.

The record shows a net $627.3K bought by insiders over 180 days, 5 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, SenesTech, Inc. insiders bought a net $627.3K of stock across 40 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Edell Michael

Chief Executive Officer

BUY

2026-08-14

1,000.0

$1.2K

GLENBROOK CAPITAL MANAGEMENT

—

BUY

2026-08-07

6,490.0

$8.4K

GLENBROOK CAPITAL MANAGEMENT

—

BUY

2026-08-06

15,000.0

$19.4K

GLENBROOK CAPITAL MANAGEMENT

—

BUY

2026-07-20

35,000.0

$51.6K

Edell Michael

Chief Executive Officer

BUY

2026-07-07

1,000.0

$1.4K

40 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 35 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

SABBY MANAGEMENT, LLC

141,756.0 sh

$211.2K

RENAISSANCE TECHNOLOGIES LLC

82,616.0 sh

$123.1K

CITADEL ADVISORS LLC

46,671.0 sh

$69.5K

GEODE CAPITAL MANAGEMENT, LLC

44,339.0 sh

$66.1K

VANGUARD CAPITAL MANAGEMENT LLC

34,762.0 sh

$51.8K

5%+ owners

13D = intent to influence · 13G = passive

GLENBROOK CAPITAL MANAGEMENT

ACTIVIST 13D · 2026-07-23

19.95%

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

State Street Balanced Index Fund

$1.1K POSITION · AS OF 2026-03-31

0.0%

Fidelity Extended Market Index Fund

$61.8K POSITION · AS OF 2026-02-28

0.0%

VANGUARD EXTENDED MARKET INDEX FUND

$57.0K POSITION · AS OF 2026-03-31

0.0%

Fidelity Series Total Market Index Fund

$10.6K POSITION · AS OF 2026-02-28

0.0%

Fidelity Total Market Index Fund

$2.0K POSITION · AS OF 2026-02-28

0.0%

VANGUARD TOTAL STOCK MARKET INDEX FUND

$13.3K POSITION · AS OF 2026-03-31

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$2.2M	$1.9M	$1.2M	$1.0M
GROSS PROFIT	$1.4M	$1.0M	$539.0K	$464.0K
OPERATING INCOME	$-6.5M	$-6.2M	$-7.7M	$-9.7M
NET INCOME	$-6.4M	$-6.2M	$-7.7M	$-9.7M
EPS (DILUTED)	-1.95	-8.86	-115.10	-148.08
OPERATING CASH FLOW	$-5.8M	$-6.0M	$-7.6M	$-8.6M
CASH	$7.6M	$1.3M	$5.4M	$4.8M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE